Simulations Plus, Inc. announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired for its previously disclosed acquisition by Altaris, LLC via SP Evolution HoldCo II, LLC. This expiration satisfies a key regulatory condition required to close the merger transaction. The deal remains subject to customary closing conditions, including shareholder approval and receipt of specific regulatory approvals in France. Management expects the transaction to close in the second half of calendar 2026, pending satisfaction or waiver of remaining conditions. Simulations Plus operates in the pharmaceutical software industry, providing model-informed and AI-accelerated drug development solutions.
